文献速递外周动脉疾病

糖尿病合并慢性肢体威胁性缺血患者的治疗结局

Treatment outcomes in diabetic patients with chronic limb-threatening ischemia.
PubMed 文献 · J Vasc Surg · 2018-03-22

基于美国外科质量改进计划血管模块2011至2014年数据,比较糖尿病与非糖尿病慢性肢体威胁性缺血患者的下肢旁路或腔内血运重建围术期结局。调整基线差异后,糖尿病与非糖尿病患者的30天死亡率相似,糖尿病与更低的MALE风险相关,且入院时长和再入院率的差异不再显著。

要点

  • 糖尿病合并CLTI患者更常表现为组织缺失(71% vs 47%,P < .001)并更倾向接受腔内治疗(41% vs 29%,P < .001)。
  • 调整基线差异后,糖尿病与非糖尿病患者的30天死亡率相似(开放手术:OR 1.1,95%CI 0.7-1.5;腔内治疗:OR 1.2,95%CI 0.7-2.0)。
  • 调整后糖尿病与更低的MALE风险相关(OR 0.7,95%CI 0.6-0.9),而MACE差异不再显著(OR 1.2,95%CI 0.9-1.6)。

核心结论

  • 接受血运重建的糖尿病合并CLTI患者与非糖尿病患者的30天结局相似,尽管糖尿病与旁路术后更低的MALE风险相关。
  • 糖尿病患者的入院时长延长和再入院率升高并非源于糖尿病本身,而可能继发于其他基线合并症,如更高的组织缺失率。
  • 对糖尿病合并CLTI患者下肢旁路术后围术期结局更差的担忧缺乏依据,不应因此阻碍医生实施开放旁路手术。

研究设计与样本

  • 使用美国外科质量改进计划血管模块2011至2014年数据,识别因CLTI接受下肢血运重建的患者。
  • 比较糖尿病与非糖尿病患者的临床表现、合并症、手术方式和30天结局,并采用多变量逻辑回归调整基线差异。
  • 共识别8887例接受开放(5744例;50%为糖尿病患者)或腔内(3143例;62%为糖尿病患者)治疗的患者。

主要发现

  • 糖尿病患者更年轻,更多为非白人、不吸烟和肥胖;更常表现为组织缺失(71% vs 47%,P < .001),更倾向接受腔内干预(41% vs 29%,P < .001)。
  • 未调整时30天死亡率无显著差异:开放手术3.1% vs 2.8%(P = .53),腔内治疗2.6% vs 2.1%(P = .37);调整后仍无显著差异:开放手术OR 1.1(95%CI 0.7-1.5),腔内治疗OR 1.2(95%CI 0.7-2.0)。
  • 糖尿病患者入院时长更长:开放手术8 vs 6天(P < .001),腔内治疗3 vs 2天(P < .001);30天再入院率更高:开放手术21% vs 18%(P < .01),腔内治疗20% vs 15%(P < .01);但这些差异在调整基线差异后不再显著。
  • 糖尿病患者的MACE发生率更高(7.0% vs 5.1%,P < .01),MALE发生率更低(8.1% vs 10%,P < .01)。
  • 调整后糖尿病与更低的MALE风险相关(OR 0.7,95%CI 0.6-0.9),而MACE差异不再显著(OR 1.2,95%CI 0.9-1.6)。

临床怎么用

  • 作者认为,对糖尿病合并CLTI患者下肢旁路术后围术期结局更差的担忧缺乏依据,不应因此阻碍医生实施开放旁路手术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There are conflicting reports about outcomes after infrainguinal bypass for chronic limb-threatening ischemia (CLTI) in patients with diabetes. We compared perioperative outcomes between patients with and patients without diabetes in the current era. METHODS: The National Surgical Quality Improvement Program vascular module, 2011 to 2014, was used to identify patients undergoing infrainguinal revascularization for CLTI. Patients with and without diabetes were compared in terms of presentation, comorbidities, operative approach, and 30-day outcomes. Major adverse limb events (MALEs) included 30-day major reintervention or amputation, and major adverse cardiovascular events (MACEs) included 30-day myocardial infarction, cardiac arrest, stroke, or death. Multivariable logistic regression was used to adjust for baseline differences. RESULTS: We identified 8887 patients undergoing open (5744; 50% diabetic) or endovascular (3143; 62% diabetic) treatment for CLTI. Patients with diabetes were younger and more often nonwhite, nonsmokers, and obese. Patients with diabetes presented more often with tissue loss (71% vs 47%; P < .001) and were more likely to be treated with endovascular intervention (41% vs 29%; P < .001). The 30-day mortality was similar before (open, 3.1% vs 2.8% [P = .53]; endovascular, 2.6% vs 2.1% [P = .37]) and after adjustment for baseline differences (open: odds ratio [OR], 1.1 [95% confidence interval (CI), 0.7-1.5]; endovascular: OR, 1.2 [95% CI, 0.7-2.0]). Patients with diabetes had longer lengths of stay (open, 8 vs 6 days [P < .001]; endovascular, 3 vs 2 days [P < .001]) and higher 30-day readmission rates (open, 21% vs 18% [P < .01]; endovascular, 20% vs 15% [P < .01]); however, these differences were no longer significant after adjustment for baseline differences. Patients with diabetes had a higher rate of MACEs (7.0% vs 5.1%; P < .01) and lower rate of MALEs (8.1% vs 10%; P < .01) after bypass. After adjustment, patients with diabetes still had a lower rate of MALEs (OR, 0.7; 95% CI, 0.6-0.9) but no longer had a higher rate of MACEs (OR, 1.2; 95% CI, 0.9-1.6). CONCLUSIONS: CLTI patients with diabetes undergoing revascularization have similar 30-day outcomes compared with those without diabetes, although they appear to be at lower risk for MALEs after bypass. Prolonged length of stay and readmission in patients with diabetes is not due to underlying diabetic disease but likely secondary to other baseline comorbidities, such as higher rates of tissue loss. Concern for worse perioperative outcomes in patients with diabetes after lower extremity bypass is unsubstantiated and should not discourage a physician from performing an open bypass.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Liang P, Soden PA, Zettervall SL, et al. Treatment outcomes in diabetic patients with chronic limb-threatening ischemia. J Vasc Surg. 2018. PMID: 29576404. doi:10.1016/j.jvs.2017.11.081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。